CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- 4 Open-market buy CEO & Chairman bought 50,000 shares at an average $2.88 ($143,984)
- 4 Open-market buy CEO & Chairman bought 150,000 shares at an average $2.98 ($446,794)
- 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $3.00 ($599,316)
- 4/A Grant or award Director acquired 312,612 shares (grant or award)
- 4 Open-market buy CEO & Chairman bought 400,000 shares at $2.83 ($1,132,400)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Vice Chairman and President bought 89,600 shares at $2.79 ($250,396)
- 4 Grant or award Director acquired 312,612 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO & Chairman bought 400,000 shares at $2.78 ($1,113,560)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO & Chairman bought 35,000 shares at an average $3.04 ($106,317)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.13 ($312,865)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.11 ($310,796)
- 4 Open-market buy CEO & Chairman bought 750,000 shares at $3.09 ($2,315,325)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $3.04 ($303,569)
- 4 Open-market buy CEO & Chairman bought 150,000 shares at an average $3.03 ($455,009)
- 4 Open-market buy CEO & Chairman bought 350,000 shares at an average $2.98 ($1,041,817)
Page 9 of 106 · 2,118 filings